FIRST-TRIMESTER SERUM SFRP-4 LEVELS IN RELATION TO BMI AND ORAL GLUCOSE TOLERANCE TEST OUTCOMES IN PREGNANT WOMEN
Objectives: The goal of this study is to evaluate Secreted Frizzled Related Protein 4 as Potential Biomarkers for GDM. Objective is to estimate the levels of SFRP-4 during first trimester of pregnancy. Methods: The study was conducted in the Department of Biochemistry. Total of 100 pregnant women attending their first prenatal examination between 6 and 13 weeks of gestation (1st Screening) at MMMCH Solan Hospital. Serum SFRP-4 levels were measured using EnzymeLinked Immunosorbent Assay (ELISA). Results: When categorized based on the BMI, 6 participants were having BMI less than 18.5 indicating under-weight, 60 participants had BMI between 18.5 to 24.9 (normal weight), while 27 participants had BMI = 25 – 29.9 indicating overweight and remaining 7 participants had BMI above 30 which signifies obese. The average BMI of the 100 participants was found to be 23.9 ± 4.17, mean SFRP-4 value was 2.50 ± 2.67 ng/ml and mean OGTT was 119.6 ± 24.35 mg/dl. Conclusion: An increase in circulating SFRP-4 across BMI categories. A positive relationship of SFRP-4 with OGTT values and BMI indicates impaired glucose handling.
Authors
- Samiksha Arya
- Monika Jindal (ORCID: https://orcid.org/0000-0001-8804-0848)
- Bharti Kwatra
Publication Details
- Journal
- International Journal of Drug Delivery Technology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.25258/ijddt.16.80s.143
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00